{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cardiovascular diseases", "immunosuppression", "kidney transplantation", "organ rejection", "polymorphism"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38928269", "DateCompleted": {"Year": "2024", "Month": "06", "Day": "27"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "05"}, "Article": {"Language": ["eng"], "ELocationID": ["6562", "10.3390/ijms25126562"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "14"}], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "25", "Issue": "12", "PubDate": {"Year": "2024", "Month": "Jun", "Day": "14"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "The Importance of the FUT2 rs602662 Polymorphism in the Risk of Cardiovascular Complications in Patients after Kidney Transplantation.", "Abstract": {"AbstractText": ["The FUT2 gene encodes an enzyme called \u03b1-1,2-fucosyltransferase, which is involved in the formation of blood group antigens AB0(H) and is also involved in the processes of vitamin B12 absorption and its transport between cells. FUT2 gene polymorphisms are associated with vitamin B12 levels in the body. Vitamin B12 deficiency associated with hyperhomocysteinemia is a major risk factor for cardiovascular diseases (CVDs), which are one of the main causes of death in patients after kidney transplantation. The aim of our study was to determine the impact of the rs602662 (G>A) polymorphism of the FUT2 gene on the functionality of transplanted kidneys and the risk of CVD in patients after kidney transplantation. The study included 402 patients treated with immunosuppression (183 patients taking cyclosporine (CsA) and 219 patients taking tacrolimus (TAC)). The analysis of the FUT2 rs602662 (G>A) polymorphism was performed using real-time PCR. Patients with CsA were more likely to be underweight (1.64% vs. 0.91%) and obese (27.87% vs. 15.98%), while those taking TAC were more likely to be of normal weight (39.27%) or overweight (43.84%). No statistically significant differences were observed comparing the mean blood pressure, both systolic and diastolic. The renal profile showed a higher median urea nitrogen concentration in patients with CsA (26.45 mg/dL (20.60-35.40) vs. 22.95 mg/dL (17.60-33.30), <i>p</i> = 0.004). The observed frequency of rs602662 alleles of the FUT2 gene was similar in the analyzed groups. The A allele was present in 43.7% of patients with CsA and 41.1% of those taking TAC (OR = 0.898; 95% CI: 0.678-1.189; <i>p</i> = 0.453). In the group with CsA, the GG genotype was present in 32.2% of patients, the GA in 48.1% and the AA in 19.7%. A similar distribution was obtained in the TAC group: GG-33.8%, GA-50.2%, and AA-16.0%. An association of genotypes containing the G allele with a higher incidence of hypertension was observed. The G allele was present in 65% of people with hypertension and in 56% of patients with normal blood pressure (<i>p</i> = 0.036). Moreover, the evaluation of the renal parameters showed no effect of the FUT2 polymorphism on the risk of organ rejection because the levels of creatinine, eGFR, potassium, and urea nitrogen were prognostic of successful transplantation. Our results suggest that the rs6022662 FUT2 polymorphism may influence the risk of cardiovascular diseases."]}, "AuthorList": [{"Identifier": ["0000-0003-4870-0156"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery and Transplantology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland."}], "LastName": "Kotowski", "ForeName": "Maciej J\u00f3zef", "Initials": "MJ"}, {"Identifier": ["0000-0001-9136-8406"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery and Transplantology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland."}], "LastName": "Ostrowski", "ForeName": "Piotr", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Physical Culture Sciences, University of Szczecin, 70-453 Szczecin, Poland."}], "LastName": "Sie\u0144ko", "ForeName": "Jerzy", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, \u017bo\u0142nierska 48, 71-230 Szczecin, Poland."}], "LastName": "Czerny", "ForeName": "Bogus\u0142aw", "Initials": "B"}, {"Identifier": ["0000-0002-4742-5271"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery and Transplantology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland."}], "LastName": "Tejchman", "ForeName": "Karol", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Pathology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland."}], "LastName": "Machali\u0144ski", "ForeName": "Bogus\u0142aw", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "G\u00f3rska", "ForeName": "Aleksandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Women's Diseases, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland."}], "LastName": "Mrozikiewicz", "ForeName": "Aleksandra E", "Initials": "AE"}, {"Identifier": ["0000-0001-5455-8315"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Personalized Medicine and Cell Therapy, Regional Blood Center, Marceli\u0144ska 44, 60-354 Poznan, Poland."}], "LastName": "Bogacz", "ForeName": "Anna", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "EC 2.4.1.-", "NameOfSubstance": "Fucosyltransferases"}, {"RegistryNumber": "EC 2.4.1.69", "NameOfSubstance": "Galactoside 2-alpha-L-fucosyltransferase"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunosuppressive Agents"}, {"RegistryNumber": "83HN0GTJ6D", "NameOfSubstance": "Cyclosporine"}, {"RegistryNumber": "WM0HAQ4WNM", "NameOfSubstance": "Tacrolimus"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "Fucosyltransferases"}, {"QualifierName": [], "DescriptorName": "Galactoside 2-alpha-L-fucosyltransferase"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Kidney Transplantation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["genetics", "etiology"], "DescriptorName": "Cardiovascular Diseases"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Polymorphism, Single Nucleotide"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}, {"QualifierName": [], "DescriptorName": "Genetic Predisposition to Disease"}, {"QualifierName": [], "DescriptorName": "Genotype"}, {"QualifierName": ["therapeutic use", "adverse effects"], "DescriptorName": "Immunosuppressive Agents"}, {"QualifierName": ["therapeutic use", "adverse effects"], "DescriptorName": "Cyclosporine"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Tacrolimus"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Rao N.N., Coates P.T. Cardiovascular Disease After Kidney Transplant. Semin. Nephrol. 2018;38:291\u2013297. doi: 10.1016/j.semnephrol.2018.02.008.", "ArticleIdList": ["10.1016/j.semnephrol.2018.02.008", "29753404"]}, {"Citation": "Neale J., Smith A.C. Cardiovascular risk factors following renal transplant. World J. Transplant. 2015;5:183\u2013195. doi: 10.5500/wjt.v5.i4.183.", "ArticleIdList": ["10.5500/wjt.v5.i4.183", "PMC4689929", "26722646"]}, {"Citation": "Stoumpos S., Jardine A.G., Mark P.B. Cardiovascular morbidity and mortality after kidney transplantation. Transpl. Int. 2015;28:10\u201321. doi: 10.1111/tri.12413.", "ArticleIdList": ["10.1111/tri.12413", "25081992"]}, {"Citation": "Aker S., Ivens K., Grabensee B., Heering P. Cardiovascular risk factors and diseases after renal transplantation. Int. Urol. Nephrol. 1998;30:777\u2013788. doi: 10.1007/BF02564867.", "ArticleIdList": ["10.1007/BF02564867", "10195874"]}, {"Citation": "Wu H., Sun L., Lin D.P., Shao X.X., Xia S.L., Lv M. Association of Fucosyltransferase 2 Gene Polymorphisms with Inflammatory Bowel Disease in Patients from Southeast China. Gastroenterol. Res. Pract. 2017;2017:4148651. doi: 10.1155/2017/4148651.", "ArticleIdList": ["10.1155/2017/4148651", "PMC5266819", "28167958"]}, {"Citation": "Yuan M., Itzkowitz S.H., Palekar A., Shamsuddin A.M., Phelps P.C., Trump B.F., Kim Y.S. Distribution of blood group antigens A, B, H, Lewis A and Lewis B in human normal, fetal, and malignant colonic tissue. Cancer Res. 1985;45:4499\u20134511.", "ArticleIdList": ["4028031"]}, {"Citation": "Kelly R.J., Rouquier S., Giorgi D., Lennon G.G., Lowe J.B. Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J. Biol. Chem. 1995;270:4640\u20134649. doi: 10.1074/jbc.270.9.4640.", "ArticleIdList": ["10.1074/jbc.270.9.4640", "7876235"]}, {"Citation": "Bustamante M., Standl M., Bassat Q., Vilor-Tejedor N., Medina-Gomez C., Bonilla C., Ahluwalia T.S., Bacelis J., Bradfield J.P., Tiesler C.M., et al. A genome-wide association metaanalysis of diarrhoeal disease in young children identifies FUT2 locus and provides plausible biological pathways. Hum. Mol. Genet. 2016;25:4127\u20134142. doi: 10.1093/hmg/ddw264.", "ArticleIdList": ["10.1093/hmg/ddw264", "PMC5291237", "27559109"]}, {"Citation": "Tian C., Hromatka B.S., Kiefer A.K., Eriksson N., Noble S.M., Tung J.Y., Hinds D.A. Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat. Commun. 2017;8:599. doi: 10.1038/s41467-017-00257-5.", "ArticleIdList": ["10.1038/s41467-017-00257-5", "PMC5605711", "28928442"]}, {"Citation": "Smyth D.J., Cooper J.D., Howson J.M., Clarke P., Downes K., Mistry T., Stevens H., Walker N.M., Todd J.A. FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection. Diabetes. 2011;60:3081\u20133084. doi: 10.2337/db11-0638.", "ArticleIdList": ["10.2337/db11-0638", "PMC3198057", "22025780"]}, {"Citation": "Ellinghaus D., Ellinghaus E., Nair R.P., Stuart P.E., Esko T., Metspalu A., Debrus S., Raelson J.V., Tejasvi T., Belouchi M., et al. Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am. J. Hum. Genet. 2012;90:636\u2013647. doi: 10.1016/j.ajhg.2012.02.020.", "ArticleIdList": ["10.1016/j.ajhg.2012.02.020", "PMC3322238", "22482804"]}, {"Citation": "Tang H., Jin X., Li Y., Jiang H., Tang X., Yang X., Cheng H., Qiu Y., Chen G., Mei J., et al. A large-scale screen for coding variants predisposing to psoriasis. Nat. Genet. 2013;46:45. doi: 10.1038/ng.2827.", "ArticleIdList": ["10.1038/ng.2827", "24212883"]}, {"Citation": "Jostins L., Ripke S., Weersma R.K., Duerr R.H., McGovern D.P., Hui K.Y., Lee J.C., Schumm L.P., Sharma Y., Anderson C.A., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119\u2013124. doi: 10.1038/nature11582.", "ArticleIdList": ["10.1038/nature11582", "PMC3491803", "23128233"]}, {"Citation": "McGovern D.P., Jones M.R., Taylor K.D., Marciante K., Yan X., Dubinsky M., Ippoliti A., Vasiliauskas E., Berel D., Derkowski C., et al. Fucosyltransferase2 (FUT2)non-secretor status is associated with Crohn\u2019s disease. Hum. Mol. Genet. 2010;19:3468\u20133476. doi: 10.1093/hmg/ddq248.", "ArticleIdList": ["10.1093/hmg/ddq248", "PMC2916706", "20570966"]}, {"Citation": "Hazra A., Kraft P., Selhub J., Giovannucci E.L., Thomas G., Hoover R.N., Chanock S.J., Hunter D.J. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat. Genet. 2008;40:1160\u20131162. doi: 10.1038/ng.210.", "ArticleIdList": ["10.1038/ng.210", "PMC2673801", "18776911"]}, {"Citation": "Lin X., Lu D., Gao Y., Tao S., Yang X., Feng J., Tan A., Zhang H., Hu Y., Qin X., et al. Genome-wide association study identifies novel loci associated with serum level of vitamin B12 in Chinese men. Hum. Mol. Genet. 2012;21:2610\u20132617. doi: 10.1093/hmg/dds062.", "ArticleIdList": ["10.1093/hmg/dds062", "22367966"]}, {"Citation": "Tanwar V.S., Chand M.P., Kumar J., Garg G., Seth S., Karthikeyan G., Sengupta S. Common variant in FUT2 gene is associated with levels of vitamin B(12) in Indian population. Gene. 2013;515:224\u2013228. doi: 10.1016/j.gene.2012.11.021.", "ArticleIdList": ["10.1016/j.gene.2012.11.021", "23201895"]}, {"Citation": "da Silva Pontes K.S., Klein M.R.S.T., da Costa M.S., de Carvalho Rosina K.T., Barreto A.P.M.M., Silva M.I.B., da Silveira Rioja S. Vitamin B12 status in kidney transplant recipients: Association with dietaryintake, body adiposity and immunosuppression. Br. J. Nutr. 2019;122:450\u2013458. doi: 10.1017/S0007114519001417.", "ArticleIdList": ["10.1017/S0007114519001417", "31280734"]}, {"Citation": "Cimino F.M., Snyder K.A. Primary care of the solid organ transplant recipient. Am. Fam. Physician. 2016;93:203\u2013210.", "ArticleIdList": ["26926613"]}, {"Citation": "Neuberger J.M., Bechstein W.O., Kuypers D.R., Burra P., Citterio F., De Geest S., Duvoux C., Jardine A.G., Kamar N., Kr\u00e4mer B.K., et al. Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: A guidance report and clinical checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) group. Transplantation. 2017;101:S1\u2013S56. doi: 10.1097/TP.0000000000001651.", "ArticleIdList": ["10.1097/TP.0000000000001651", "28328734"]}, {"Citation": "Chan W., Bosch J.A., Jones D., McTernan P.G., Phillips A.C., Borrows R. Obesity in kidney transplantation. J. Ren. Nutr. 2014;24:1\u201312. doi: 10.1053/j.jrn.2013.09.002.", "ArticleIdList": ["10.1053/j.jrn.2013.09.002", "24231063"]}, {"Citation": "Aulagnon F., Scemla A., DeWolf S., Burra P., Citterio F., De Geest S., Duvoux C., Jardine A.G., Kamar N., Kr\u00e4mer B.K., et al. Diarrhea after kidney transplantation: A new look at a frequent symptom. Transplatation. 2014;98:806\u2013816. doi: 10.1097/TP.0000000000000335.", "ArticleIdList": ["10.1097/TP.0000000000000335", "25073040"]}, {"Citation": "Shin H.S., Chandraker A. Causes and management of postrenal transplant diarrhea: An underappreciated cause of transplant-associated morbidity. Curr. Opin. Nephrol. Hypertens. 2017;26:484\u2013493. doi: 10.1097/MNH.0000000000000368.", "ArticleIdList": ["10.1097/MNH.0000000000000368", "28863048"]}, {"Citation": "Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation. 1996;61:1029\u20131037. doi: 10.1097/00007890-199604150-00008.", "ArticleIdList": ["10.1097/00007890-199604150-00008", "8623181"]}, {"Citation": "Kamar N., Faure P., Dupuis E., Cointault O., Joseph-Hein K., Durand D., Moreau J., Rostaing L. Villous atrophy induced by mycophenolate mofetil in renal transplant patients. Transpl. Int. 2004;17:463\u2013467. doi: 10.1111/j.1432-2277.2004.tb00471.x.", "ArticleIdList": ["10.1111/j.1432-2277.2004.tb00471.x", "15322747"]}, {"Citation": "Maes B.D., Dalle I., Oellerich M., Armstrong V.W., Evenepoel P., Geypens B., Kuypers D., Shipkova M., Geboes K., Vanrenterghem Y.F.C. Erosive enterocolitis in mycophenolate mofetil-treated in renal transplant recipients with persistent afebrile diarrhea. Transplantation. 2003;75:665\u2013672. doi: 10.1097/01.TP.0000053753.43268.F0.", "ArticleIdList": ["10.1097/01.TP.0000053753.43268.F0", "12640307"]}, {"Citation": "Ganguly P., Alam S.F. Role of homocysteine in the development of cardiovascular disease. Nutr. J. 2015;14:6. doi: 10.1186/1475-2891-14-6.", "ArticleIdList": ["10.1186/1475-2891-14-6", "PMC4326479", "25577237"]}, {"Citation": "Shipton M., Thachil J. Vitamin B12 deficiency\u2014A 21st century perspective. Clin. Med. 2015;15:145\u2013150. doi: 10.7861/clinmedicine.15-2-145.", "ArticleIdList": ["10.7861/clinmedicine.15-2-145", "PMC4953733", "25824066"]}, {"Citation": "Jardine A.G., Gaston R.S., Fellstrom B.C., Holdaas H. Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet. 2011;378:1419\u20131427. doi: 10.1016/S0140-6736(11)61334-2.", "ArticleIdList": ["10.1016/S0140-6736(11)61334-2", "22000138"]}, {"Citation": "Koda Y., Tachida H., Pang H., Liu Y., Soejima M., Ghaderi A.A., Takenaka O., Kimura H. Contrasting patterns of polymorphisms at the ABO-secretor gene (FUT2) and plasma alpha(1,3)fucosyltransferase gene (FUT6) in human populations. Genetics. 2001;158:747\u2013756. doi: 10.1093/genetics/158.2.747.", "ArticleIdList": ["10.1093/genetics/158.2.747", "PMC1461689", "11404338"]}, {"Citation": "Hazra A., Kraft P., Lazarus R., Chen C., Chanock S.J., Jacques P., Selhub J., Hunter D.J. Genome wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum. Mol. Genet. 2009;18:4677\u20134687. doi: 10.1093/hmg/ddp428.", "ArticleIdList": ["10.1093/hmg/ddp428", "PMC2773275", "19744961"]}, {"Citation": "Tanaka T., Scheet P., Giusti B., Bandinelli S., Piras M.G., Usala G., Lai S., Mulas A., Corsi A.M., Vestrini A., et al. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am. J. Hum. Genet. 2009;84:477\u2013482. doi: 10.1016/j.ajhg.2009.02.011.", "ArticleIdList": ["10.1016/j.ajhg.2009.02.011", "PMC2667971", "19303062"]}, {"Citation": "R Core Team  R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2021.  [(accessed on 2 June 2023)].  Available online:  https://www.R-project.org/"}, {"Citation": "Gonzalez J.R., Moreno V. SNPassoc: SNPs-Based Whole Genome Association Studies. R package Version 2.0\u20132. 2020.  [(accessed on 18 April 2024)].  Available online:  https://CRAN.R-project.org/package=SNPassoc."}, {"Citation": "Patil I. Visualizations with statistical details: The g\u2018gstatsplot\u2019 approach. J. Open Source Softw. 2021;6:3167. doi: 10.21105/joss.03167.", "ArticleIdList": ["10.21105/joss.03167"]}]}], "History": [{"Year": "2024", "Month": "5", "Day": "7"}, {"Year": "2024", "Month": "6", "Day": "5"}, {"Year": "2024", "Month": "6", "Day": "12"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "1", "Minute": "6"}, {"Year": "2024", "Month": "6", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["38928269", "PMC11203847", "10.3390/ijms25126562", "ijms25126562"]}}]}